Form 4: Butterfly Network CFO Expands Stake with RSU Grant

Butterfly Network's EVP and CFO, John N. Doherty, received a grant of 274,953 restricted stock units, increasing his beneficial ownership.

Summary

• John N. Doherty, Executive Vice President and Chief Financial Officer of Butterfly Network, Inc. (BFLY), was granted 274,953 shares of Class A Common Stock.
• The grant consists of restricted stock units (RSUs), where each RSU represents the right to receive one share upon vesting.
• These RSUs will vest in three equal annual installments, commencing on March 1, 2027.
• Vesting is contingent upon Mr. Doherty's continued service to the company on each respective vesting date.
• Following this transaction, Mr. Doherty beneficially owns a total of 1,509,641 shares of Class A Common Stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard executive compensation practices that align management incentives with shareholder interests, without indicating any immediate operational or financial shifts.

Positives

• The grant of restricted stock units increases insider ownership, aligning management's interests with those of shareholders.
• The vesting schedule acts as a retention mechanism, incentivizing the CFO to remain with the company for future performance.

Negatives

• The shares are restricted stock units and do not represent immediate, unrestricted ownership or a cash transaction for the executive.
• Vesting is subject to continued service, meaning the shares are not guaranteed if the executive departs before vesting dates.

Risks

• The primary risk is the forfeiture of unvested restricted stock units if the reporting person's service to the company ceases before the scheduled vesting dates.

Future Outlook

The future outlook for the granted RSUs is tied to the vesting schedule, with shares becoming fully owned in three equal annual installments starting March 1, 2027, provided the CFO maintains continuous service.

Industry Context

StockSavvy.ai notes that granting restricted stock units to key executives like the CFO is a common practice in the technology and healthcare sectors. This form of equity compensation is widely used to attract, retain, and motivate top talent by aligning their long-term financial interests with the company's performance and shareholder value creation.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) for executive compensation is a standard practice across various industries, including medical technology and diagnostics, similar to companies like Intuitive Surgical (ISRG) or Medtronic (MDT) which frequently utilize equity grants to incentivize their leadership.
• The multi-year vesting schedule (three equal annual installments) is typical for executive equity awards, designed to promote long-term commitment and performance, comparable to vesting structures seen at companies such as Dexcom (DXCM) or Tandem Diabetes Care (TNDM).

Stakeholder Impact

• Shareholders: Increased alignment of the CFO's financial interests with long-term shareholder value through equity ownership.
• Employees: May signal stability in executive leadership and a commitment to retaining key personnel.

Next Steps

• The restricted stock units will begin to vest in three equal annual installments starting March 1, 2027.
• Future Form 4 filings will report the vesting and conversion of these RSUs into Class A Common Stock.

Key Dates

Keywords

Butterfly Network, BFLY, Form 4, SEC filing, Restricted Stock Units, RSU grant, insider ownership, executive compensation, John N. Doherty, CFO